| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| enmd-2076 | aurora kinase a | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Leukemia Myelocytic Acute[MeSHID:D015470] Liver carcinoma[MeSHID:D006528] Malignant neoplasm of liver[MeSHID:D008113] Triple Negative Breast Neoplasms[MeSHID:D064726] |
0.37 | phase 2 | unknown |
| enmd-2076 | aurora kinase a | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Leukemia Myelocytic Acute[MeSHID:D015470] Liver carcinoma[MeSHID:D006528] Malignant neoplasm of liver[MeSHID:D008113] Triple Negative Breast Neoplasms[MeSHID:D064726] |
0.37 | phase 2 | inhibitor |
| click here to return to the previous page | ||||||||